Proteomics in Cell Biology and Disease Mechanisms, due to take place 30 March – 01 April 2020, will not take place as a face-to-face meeting. This decision was made due to the fact that international travel restrictions have just been put in place for staff on their Campus, in response to the rapidly evolving situation with regard to covid19.
PharmaFluidics will be attending the 4th Proteomics in Cell Biology and Disease Mechanisms conference at the Wellcome Genome campus, UK, from 30 March – 1 April 2020.
Recent technological and computational advances in high-throughput methods and multi-omics big data integration have propelled the field of proteomics forward, enabling countless applications in biology and medicine. This year, the programme will be particularly focused on computational aspects of proteomics, including databases and artificial intelligence approaches in proteomics and health care. The conference will also highlight the latest developments in spatial and structural proteomics, protein-protein interactions and post-translational modifications, and their applications in medicine.
This is a joint symposium with EMBL.
Our experts will be waiting for you at our booth to explain our µPAC™ technology.
Find out more on the conference website.